EBV based cancer prevention and therapy in nasopharyngeal carcinoma
Abstract Epstein–Barr virus is an important cancer causing virus. Nasopharyngeal carcinoma is an infection-related cancer strongly driven by Epstein–Barr virus. In this cancer model, we identified the major host targets of latent membrane protein 1 which is a driving oncogene encoded by Epstein–Barr...
Saved in:
Main Author: | Ya Cao |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/8fadfabaee38471eb4d3e1eb3e25a95b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma
by: Corey Smith, et al.
Published: (2021) -
Cone Beam CT (CBCT) Based Synthetic
CT Generation Using Deep Learning
Methods for Dose Calculation of Nasopharyngeal Carcinoma Radiotherapy
by: Xudong Xue PhD, et al.
Published: (2021) -
In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast
by: Lee O, et al.
Published: (2011) -
Current strategies for the prevention of breast cancer
by: Advani P, et al.
Published: (2014) -
A New Tool for CRISPR-Cas13a-BasedCancer Gene Therapy
by: Jinliang Gao, et al.
Published: (2021)